Normal Growth despite Combined Pituitary Hormone Deficiency
- 25 April 2019
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 92 (2) , 133-142
Abstract
Background: The paradox of normal growth despite a lack of growth hormone (GH) is an unexplained phenomenon described in some pathological (sellar, suprasellar, and hypothalamic disorders) and overgrowth syndromes. It has been suggested that the paradoxical growth is due to other GH variants, GH-like moieties, prolactin, insulin, insulin-like growth factors (IGFs), and unidentified serum factors or growth mechanisms. The objective of this study was to determine the mechanism underlying this normal growth without GH. Case Description: We describe here growth, hormonal, and genetic analyses for an adolescent boy with panhypopituitarism who achieved an adult height above his genetic potential. Results: Normal growth was observed despite low serum GH, IGF-I, IGF-II, IGF binding protein 3 (IGFBP-3) and acid labile subunit (ALS) concentrations, but the IGF-II/IGFBP-3 molar ratio was slightly high. Panhypopituitarism was associated with a heterozygous missense mutation of HESX1, with variable penetrance in heterozygous relatives. Exome analysis detected heterozygous missense mutations of various genes involved in intracellular signaling pathways. The growth-promoting activity of the patient’s serum was unable to induce AKT phosphorylation in the MCF-7 cell line. Conclusion: The high IGF-II/IGFBP-3 molar ratio was not the cause of the sustained high growth velocity, due to the low affinity of IGF-II for IGF type 1 receptor. The key finding was the HESX1 mutation, as similar cases have been described before, suggesting a common mechanism for growth without GH. However, the variable penetrance of this variant in heterozygous relatives suggests that modifier genes or mechanisms involving combinations with mutations of other genes involved in intracellular signaling pathways might be responsible.Keywords
This publication has 38 references indexed in Scilit:
- Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short statureProceedings of the National Academy of Sciences, 2012
- Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3β SignalingMolecular and Cellular Biology, 2010
- Growth without Growth Hormone and Similar Dysmorphic Features in Three Patients with Sporadic Combined Pituitary Hormone DeficienciesHormone Research in Paediatrics, 2009
- The epigenetic imprinting defect of patients with Beckwith—Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 regionJournal of Medical Genetics, 2006
- OvergrowthBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasiaHuman Molecular Genetics, 2001
- A Boy with Normal Growth in Spite of Growth Hormone Deficiency after Resection of a Suprasellar TeratomaEndocrine Journal, 2000
- Children with CraniopharyngiomaActa Paediatrica, 1988
- GROWTH WITHOUT GROWTH HORMONE: EVIDENCE FOR A POTENT CIRCULATING HUMAN GROWTH FACTORThe Lancet, 1986
- Insulin-like Growth Factors I and II, Prolactin, and Insulin in 19 Growth Hormone-Deficient Children with Excessive, Normal, or Decreased Longitudinal Growth after Operation for CraniopharyngiomaNew England Journal of Medicine, 1983